Literature DB >> 28403000

The Combined Use of a Neurocutaneous Flap and the Ilizarov Technique for Reconstruction of Large Soft Tissue Defects and Bone Loss in the Tibia.

Jia Xu1, Wan-Run Zhong, Liang Cheng, Chun-Yang Wang, Gen Wen, Pei Han, Yi-Min Chai.   

Abstract

BACKGROUND: Management of posttraumatic large soft tissue defects and bone loss remains a therapeutic and surgical challenge for orthopedic surgeons. We assessed the use of a neurocutaneous flap and the Ilizarov technique in the reconstruction of severe composite defects in the tibia.
METHODS: We retrospectively reviewed 18 consecutive patients with trauma-related soft tissue defects and bone loss. The size of the soft tissue defect ranges from 8 × 9 cm to 14 × 18 cm. The mean size of bone loss was 4.5 cm. A great saphenous neurocutaneous flap or sural neurocutaneous flap was created to reconstruct the soft tissue defect. The Ilizarov external fixator was applied to reconstruct bony loss by means of distraction osteogenesis.
RESULTS: The mean follow-up period was 38.8 months. All transferred flaps survived completely. The area covered ranged from 9 × 10 cm to 15 × 20 cm. The mean distraction length and duration of use of the external fixator were 6 cm and 11.4 months, respectively. All patients achieved final union. Complications of superficial pin-tract infections and mild Achilles tendon contracture were observed, but these were resolved over time. All patients were satisfied with the outcome of the surgery.
CONCLUSIONS: A well-vascularized neurocutaneous flap is a safe and effective option in lower extremity reconstruction under a stable mechanical environment, which can be created using the Ilizarov technique. It is a good option for reconstructing severe complex defects in the lower limb.

Entities:  

Mesh:

Year:  2017        PMID: 28403000     DOI: 10.1097/SAP.0000000000000921

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  7 in total

1.  The efficiency of internal fixation with bone grafting at docking sites after bone transport for treatment of large segmental tibial bone defects.

Authors:  Maimaiti Xiayimaierdan; Jinyong Huang; Chenchen Fan; Feiyu Cai; Yusupu Aihemaitijiang; Zengru Xie
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Application of Ilizarov transverse tibial bone transport and microcirculation reconstruction in the treatment of chronic ischemic diseases in lower limbs.

Authors:  Qiang Zuo; Feng Gao; Huanghe Song; Jinchun Zhou
Journal:  Exp Ther Med       Date:  2018-06-18       Impact factor: 2.447

3.  A Case of Reconstruction of an Open Tibial Fracture (Gustilo-Anderson Type IIIB) With Severe Skin and Bone Loss Using Corticocancellous Bone Plugs From the Iliac Crest and an Ilizarov Frame.

Authors:  Spyridon Papagiannis; George Sinos; Ioannis Vrachnis; Stavros Balasis; Antonis Kouzelis
Journal:  Cureus       Date:  2022-02-23

4.  An alternative therapeutic strategy for infected large bone defect and massive soft-tissue loss of leg-is free flap reconstruction inevitable?

Authors:  Yaxing Li; Yu Chen; Tingjiang Gan; Boquan Qin; Xi Liu; Hui Zhang
Journal:  Int Orthop       Date:  2021-08-02       Impact factor: 3.075

5.  Comparison of Monolateral External Fixation and Internal Fixation for Skeletal Stabilisation in the Management of Small Tibial Bone Defects following Successful Treatment of Chronic Osteomyelitis.

Authors:  Yicun Wang; Hui Jiang; Zhantao Deng; Jiewen Jin; Jia Meng; Jun Wang; Jianning Zhao; Guojing Sun; Hongbo Qian
Journal:  Biomed Res Int       Date:  2017-11-26       Impact factor: 3.411

6.  Using the Ilizarov technique to treat limb shortening after replantation of a severed lower limb: a case report.

Authors:  Qing Jiang; Kai Huang; Yiyang Liu; Genying Chi
Journal:  Ann Transl Med       Date:  2020-08

7.  Bone Transport for Treatment of Traumatic Composite Tibial Bone and Soft Tissue Defects: Any Specific Needs besides the Ilizarov Technique?

Authors:  Runguang Li; Guozheng Zhu; Chaojie Chen; Yirong Chen; Gaohong Ren
Journal:  Biomed Res Int       Date:  2020-02-24       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.